TheEdgeResearch
Home / Stocks / HLUN

HEALTHeUNIVERSE, Inc. (HLUN)

OTC Healthcare Biotechnology
$0.00 ▲ +0.00%
Market Cap
$11,778
Sector
Healthcare
Industry
Biotechnology
Beta
6.11
52-Wk Range
0.00001-0.0001
CEO
Vipul Dev
Country
US
Currency
USD

HEALTHeUNIVERSE, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Covina, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $11,778. Its beta of 6.11 implies it has historically moved more than the broad market.

Company profile
Exchange
Other OTC
Employees
0
IPO date
2013-02-20
Headquarters
Covina, CA, US
About HEALTHeUNIVERSE, Inc.

Healtheuniverse, Inc. operates as a biotechnology firm dedicated to exploring, creating, and bringing to market a diverse range of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. A key focus involves advancing regenerative medicine and stem cell treatments, specifically employing non-embryonic adult stem cells. These therapies are designed for applications across multiple medical specialties, such as reconstructive and plastic surgery, orthopedics, vascular procedures, heart surgery, and wound management. Additionally, the company extends its expertise through consulting services, assisting various enterprises with strategic marketing, organizational structuring, and securing funding for their initiatives. Established in 2001, its primary operational base is located in Covina, California.

Comparable companies

HEALTHeUNIVERSE, Inc. is most often compared with the following Healthcare names:

ARDSEVLOINFIQNNLXOZYMFPXMDQBIOTRVNVAXXXSNX
More research on HLUN
HLUN technical analysis HLUN TheEdge Score Compare against peers
Open full interactive analysis & DCF →